You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DIPG

Showing 26 - 50 of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced

Completed
Has Results
  • Diffuse Intrinsic Pontine Glioma
  • Panobinostat Nanoparticle Formulation MTX110
  • Convection-Enhanced Delivery (CED)
  • San Francisco, California
    University of California, San Francisco
Feb 2, 2022

Diffuse Intrinsic Pontine Glioma Trial in China (Nimotuzumab+CRT(concurrent IMRT and TMZ))

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Nimotuzumab+CRT(concurrent IMRT and TMZ)
  • Zhengzhou, Henan, China
  • +7 more
Apr 21, 2021

Glioblastoma (GBM), DIPG, Brainstem Glioma, Pediatric Trial in Florence (Doxorubicin)

Terminated
  • Glioblastoma (GBM)
  • +7 more
  • Florence, Italy
    Meyer Children's Hospital
Feb 4, 2021

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,

Not yet recruiting
  • High Grade Glioma
  • +2 more
  • PEP-CMV
  • +2 more
  • Aurora, Colorado
  • +9 more
Jan 28, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Recurrent or Progressive Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, New Zealand (re-irradiation)

Recruiting
  • Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
  • re-irradiation
  • Westmead, New South Wales, Australia
  • +17 more
Dec 14, 2021

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Bithalamic High Grade Glioma Trial in Cincinnati (Ribociclib)

Terminated
Has Results
  • High Grade Glioma
  • +2 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 15, 2020

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

Recruiting
  • Pediatric Solid Tumor
  • +7 more
  • CLR 131
  • Palo Alto, California
  • +6 more
Nov 30, 2021

Diffuse Intrinsic Pontine Glioma or Glioblastoma Trial in Shenzhen (Immunomodulatory DC vaccine to target DIPG and GBM)

Enrolling by invitation
  • Diffuse Intrinsic Pontine Glioma or Glioblastoma
  • Immunomodulatory DC vaccine to target DIPG and GBM
  • Shenzhen, Guangdong, China
  • +2 more
Jun 10, 2020

Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • Los Angeles, California
  • +18 more
Aug 16, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic Trial in New Hyde Park (Mebendazole, Vincristine, Carboplatin)

Recruiting
  • Pilomyxoid Astrocytoma
  • +11 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Mar 3, 2021

CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

Active, not recruiting
Has Results
  • Central Nervous System Neoplasms
  • Medulloblastoma
  • Stanford, California
  • +24 more
Sep 28, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Histone H3.3-K27M Neoantigen Vaccine Therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 18, 2022

Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Glioma, Malignant
  • San Francisco, California
  • +7 more
Mar 1, 2022

Brain Cancer Trial in Orlando, Houston (Radiation Therapy)

Unknown status
  • Brain Cancer
  • Radiation Therapy
  • Orlando, Florida
  • +1 more
Jan 24, 2020

Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab

Recruiting
  • Relapsed Solid Tumor
  • +5 more
  • cemiplimab (monotherapy)
  • +3 more
  • Los Angeles, California
  • +19 more
Jan 27, 2022

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023